Great Lakes Dredge & Dock (GLDD) – Some Award Updates


Tuesday, July 01, 2025

Great Lakes Dredge & Dock Corporation is the largest provider of dredging services in the United States. In addition, Great Lakes is fully engaged in expanding its core business into the rapidly developing offshore wind energy industry. The Company has a long history of performing significant international projects. The Company employs experienced civil, ocean and mechanical engineering staff in its estimating, production and project management functions. In its over 131-year history, the Company has never failed to complete a marine project. Great Lakes owns and operates the largest and most diverse fleet in the U.S. dredging industry, comprised of approximately 200 specialized vessels. Great Lakes has a disciplined training program for engineers that ensures experienced-based performance as they advance through Company operations. The Company’s Incident-and Injury-Free® (IIF®) safety management program is integrated into all aspects of the Company’s culture. The Company’s commitment to the IIF® culture promotes a work environment where employee safety is paramount.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Awards. Yesterday, Great Lakes provided an update on some recent awards. Each of the awards adds to the Company’s significant backlog, which stood at approximately $1 billion with an additional $265 million in low bids and options pending award at the end of the first quarter. The large backlog, with a majority being higher margin capital projects, provides strong visibility for 2025 and into 2026.

Woodside LNG. The Company received Notice to Proceed from Bechtel Energy for dredging work on the Woodside Louisiana LNG project. The first phase of work, which was awarded in the second quarter of 2025, includes the construction of a ship berthing basin for use by large LNG carriers, with potential for award of two options to expand the scope of construction for additional ship berths. Dredging operations are expected to commence in early 2026.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Labor Market Shows Unexpected Strength as Job Openings Surge in May

The American labor market delivered a surprise in May, with job openings climbing to their highest point in over six months, according to fresh government data that has caught economists and Federal Reserve watchers off guard.

The Bureau of Labor Statistics reported Tuesday that available positions reached 7.76 million at the end of May, representing a substantial jump from April’s 7.39 million openings. This figure significantly exceeded analyst predictions, which had anticipated job openings would remain relatively flat at approximately 7.3 million positions.

The unexpected surge in available positions marks the strongest showing for job openings since November 2024, suggesting that despite broader economic uncertainties, employers continue to maintain robust demand for workers across various sectors.

While the job opening data painted an optimistic picture, other components of the Job Openings and Labor Turnover Survey revealed a more nuanced employment landscape. Hiring activity actually declined during the month, with companies bringing on 5.5 million new employees compared to 5.61 million in April. This translated to a hiring rate of 3.4%, down from the previous month’s 3.5%.

The data reveals what labor economists have characterized as a market in equilibrium, where demand for workers remains strong but actual hiring activity has moderated from the rapid pace seen in recent years. Both hiring and voluntary quit rates are currently operating near decade-low levels, indicating a more measured approach to job market transitions.

Interestingly, the quit rate—often viewed as a barometer of worker confidence—edged upward to 2.1% from April’s 2.0%. This modest increase suggests that while employees remain cautious about making career moves, some are beginning to show renewed confidence in finding alternative employment opportunities.

The labor market data arrives at a critical juncture for monetary policy discussions. Financial markets are closely monitoring employment trends as the Federal Reserve weighs potential interest rate adjustments in response to evolving economic conditions.

Current market expectations indicate approximately a 23% probability of a rate cut at the Fed’s July meeting, with odds rising to 96% for at least one reduction by the September meeting. The stronger-than-expected job opening figures could influence these calculations, as robust labor demand typically supports arguments against immediate monetary easing.

The employment picture becomes more complex when considering recent policy developments, including the implementation of new trade measures under the Trump administration. Economists are watching for any signs that tariff policies might be affecting hiring patterns or business confidence across different industries.

Market participants will receive additional labor market insights Thursday when the Bureau of Labor Statistics releases the comprehensive June employment report. Economists are forecasting a continued moderation in hiring activity, with projections calling for 110,000 new nonfarm payroll additions—a notable decline from recent months.

The unemployment rate is expected to tick slightly higher to 4.3%, which would represent a modest increase from the current 4.2% level. If these projections prove accurate, they would reinforce the narrative of a labor market that remains fundamentally healthy but is operating at a more sustainable pace than the breakneck hiring seen in the post-pandemic recovery period.

As one economist noted, while hiring activity remains below historical norms, the combination of low layoff rates and steady job creation suggests the labor market has achieved a state of relative stability rather than deterioration. This balance could prove beneficial for both workers and employers as the economy navigates ongoing policy transitions and global economic uncertainties.

The Strategic Imperative: Why European Healthcare and Life Sciences Companies Should Look To The U.S. Now

In a global economy reshaped by innovation and evolving policy, European Healthcare and Life Sciences companies have a unique opportunity to accelerate growth by investing in the U.S. middle market. Our new thought leadership series—developed by leading M&A professionals from CNM LLP, Cozen O’Connor, NOBLE Capital Markets, and Pathfinder Advisors LLC—dives into the strategic, operational, and financial reasons why the time to act is now.

🔹 Compressed U.S. valuations + innovation-rich sectors
🔹 Favorable budgetary, regulatory, and M&A conditions
🔹 Cross-border synergies driving sustainable global health outcomes

This first installment lays out the business case, key advantages, and regulatory shifts creating ripe conditions for transatlantic healthcare deals. Don’t miss these insights—and get ready for the July 24 webinar that takes the conversation further.

📘 Read the full article

🎙️ Save the Date: July 24 – Expert Webinar

Aurania Resources (AUIAF) – Promising New Data Highlights the Potential for a Significant Copper Discovery


Monday, June 30, 2025

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Application of two-dimensional inversion technology. Aurania Resources announced that six highly conductive anomalies have been revealed at the company’s Awacha porphyry copper target based on reprocessed data from a 2021 mobile magnetotellurics (MobileMT) survey using the latest two-dimensional (2D) inversion technology. Compared to the previously employed 1D algorithm, the 2.5D code accounts for the actual topography of the area, resulting in more accurate mapping of subsurface conductivity.

Six promising anomalies at Awacha. New inversion data has confirmed the presence of six high-conductivity anomalies that begin 250 meters from the surface and exhibit deep roots. The anomalies are of significant interest because zones of elevated conductivity often correlate with porphyry copper deposits due to the presence of conductive sulphide minerals and porphyry-related alteration.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Home Depot’s SRS Distribution to Acquire GMS Inc. in $5.5 Billion Deal

GMS Inc. (NYSE: GMS), a major distributor of specialty building products across North America, has entered into a definitive agreement to be acquired by SRS Distribution, a subsidiary of The Home Depot. The transaction, valued at approximately $5.5 billion including net debt, marks a significant step in expanding The Home Depot’s distribution capabilities through its fast-growing specialty trade arm.

Under the agreement, SRS will launch a tender offer to purchase all outstanding shares of GMS for $110.00 per share in cash—representing a 36% premium over GMS’s closing stock price on June 18, 2025. The acquisition is expected to close by the end of The Home Depot’s current fiscal year, pending regulatory approvals and a majority tender of GMS shares.

Founded in 1971, GMS has built a strong presence in the building materials sector, offering a wide range of products including wallboard, ceilings, steel framing, and complementary items through its network of over 320 distribution centers and nearly 100 tool sales and rental locations. The company’s consistent growth has been guided by a strategy focused on expanding its core product sales, growing complementary offerings, extending its platform, and driving productivity and profitability.

Following the acquisition, GMS will continue to operate under its current leadership. CEO John C. Turner Jr. and the existing senior management team will remain at the helm, overseeing day-to-day operations as part of the SRS organization.

The merger aims to significantly enhance service and fulfillment options for both residential and commercial contractors. By combining GMS’s industry leadership and product breadth with SRS’s expansive footprint—already spanning more than 800 locations—the unified business will operate over 1,200 branches and manage a delivery fleet of more than 8,000 trucks.

SRS Distribution CEO Dan Tinker emphasized the value of the partnership, stating that the integration of GMS into the SRS platform will result in a powerful distribution network capable of servicing tens of thousands of job sites daily.

This acquisition also builds on The Home Depot’s strategic use of SRS as a platform for growth. Since acquiring SRS, Home Depot has leveraged synergies including shared service offerings, cross-selling opportunities, and integration of trade credit solutions, contributing to its broader strategy of supporting professional contractors more comprehensively.

Once finalized, the deal is expected to increase The Home Depot’s capacity to serve the growing demands of the pro customer segment, strengthening its position across both residential and commercial construction markets.

AbbVie to Acquire Capstan Therapeutics in $2.1B Deal, Advancing Novel Autoimmune Treatment Technologies

AbbVie has announced a definitive agreement to acquire Capstan Therapeutics, a clinical-stage biotechnology company pioneering targeted in vivo cell engineering, in a deal valued at up to $2.1 billion. The acquisition includes Capstan’s lead asset, CPTX2309—an investigational therapy targeting B cell-mediated autoimmune diseases—as well as the company’s proprietary targeted lipid nanoparticle (tLNP) platform for RNA delivery.

This strategic move signals AbbVie’s growing commitment to reshaping the treatment landscape for autoimmune diseases. While AbbVie has long been a major player in immunology with blockbuster therapies like Humira and Rinvoq, the addition of Capstan’s in vivo CAR-T capabilities positions the company at the frontier of a new therapeutic modality.

CPTX2309 is an mRNA-based therapy that delivers an anti-CD19 chimeric antigen receptor (CAR) directly into CD8-expressing cytotoxic T cells via Capstan’s tLNP system. Unlike traditional ex vivo CAR-T therapies, which require harvesting and engineering a patient’s cells outside the body before reinfusion, CPTX2309 enables this transformation to happen in vivo. This significantly simplifies the treatment process by eliminating the need for lymphodepletion or complex manufacturing steps—making it potentially more scalable and accessible.

Targeting CD19, a well-validated marker expressed on B cells, CPTX2309 aims to deplete the autoreactive B cells responsible for driving autoimmune diseases such as lupus or multiple sclerosis. The goal is to eliminate the pathogenic immune cells and repopulate the system with naïve, healthy B cells—effectively resetting the immune system and halting disease progression.

AbbVie is not only acquiring a promising clinical candidate but also a platform technology with broad applications. Capstan’s proprietary CellSeeker™ tLNP platform can be adapted to deliver a variety of RNA payloads to specific cell types in vivo, opening possibilities far beyond autoimmune conditions. This could have future implications for oncology, infectious diseases, and more.

As part of the agreement, AbbVie will make a cash payment of up to $2.1 billion at closing, subject to customary regulatory and legal conditions, including the expiration of the waiting period under the Hart-Scott-Rodino Act.

This acquisition adds to AbbVie’s expanding immunology pipeline and enhances its positioning in next-generation therapeutic development. By integrating Capstan’s cutting-edge technology, AbbVie aims to develop new approaches that go beyond treating symptoms and instead target the root causes of autoimmune disorders.

The transaction is expected to close later this year. Capstan was advised by Centerview Partners LLC as financial advisor and Cooley LLP as legal counsel. AbbVie did not disclose its legal or advisory team.

This deal reflects a growing industry trend of major pharmaceutical companies investing heavily in advanced RNA delivery platforms and in vivo cell therapies—technologies seen as essential to the next wave of personalized medicine. With this acquisition, AbbVie reaffirms its commitment to driving innovation that transforms the standard of care for patients worldwide.

Take a moment to take a look at more emerging growth biotechnology companies by taking a look at Noble Capital Markets’ analyst Robert LeBoyer’s coverage list.

U.S. and China Cement Trade Agreement, Signaling Easing of Rare Earth and Tech Restrictions

The United States and China have confirmed the finalization of a new trade framework that aims to ease ongoing tensions over rare earth exports and high-tech restrictions, offering a cautious step forward in the complex trade relationship between the two global superpowers.

According to China’s Ministry of Commerce, the agreement outlines reciprocal actions: China will review and approve export applications for goods subject to control rules, while the United States will begin lifting a range of restrictive measures previously targeting Beijing. While the announcement did not specify which exports or restrictions will be affected, the move signals a broader effort to stabilize bilateral trade ties.

This development follows remarks from U.S. officials confirming that a framework agreement had recently been signed. The new accord builds on groundwork laid earlier this year during high-level talks in Geneva, and more recently in London, where Treasury Secretary Scott Bessent and Chinese Vice Premier He Lifeng led discussions that helped shape the final structure of the deal.

The London meetings reaffirmed both sides’ interest in implementing the Geneva consensus, which had paused a significant portion of bilateral tariffs for 90 days and introduced initial efforts to de-escalate commercial pressures. That earlier agreement had come after months of strained communications, with both countries accusing one another of delaying policy rollbacks.

Though the agreement has been received as a sign of progress, analysts have highlighted the lack of detailed commitments on critical components such as rare earth elements. These materials, essential to the production of semiconductors, electric vehicles, and defense technology, remain a key point of leverage in ongoing U.S.-China negotiations. Both countries have historically viewed rare earths as strategic assets, and any long-term easing of restrictions is expected to be handled with caution.

In addition to export concerns, tensions had also mounted over U.S. limitations on Chinese access to advanced technologies and student visa policies. The latest agreement is expected to reduce some of those barriers, although specifics have yet to be disclosed.

Observers note that while this step could bring a temporary reprieve to certain industries—particularly tech manufacturing and defense-related supply chains—significant challenges remain. The nature of the agreement, without clearly defined measures, may limit its immediate impact and leaves room for further diplomatic friction.

Financial markets reacted modestly, with shares in key industrial and tech sectors showing slight gains. Stakeholders across both countries are now expected to monitor implementation efforts closely to determine how the agreement translates into policy and trade flows on the ground.

Although the finalized trade framework provides an opening for improved relations, the success of the deal will depend on continued engagement, transparency, and measurable outcomes as the global economic landscape continues to evolve.

XOMA Acquires Turnstone in $0.34 Per Share Deal with Future Payouts

Key Points:
– XOMA will acquire Turnstone for $0.34 per share plus a CVR.
– 25.2% of shareholders have agreed to the deal.
– The acquisition expands XOMA’s biotech royalty portfolio.

In a notable development in the biotech investment landscape, XOMA Royalty Corporation has entered into a definitive agreement to acquire Turnstone Biologics Corp. in a cash and contingent value right (CVR) transaction. The acquisition underscores XOMA’s continued push to expand its royalty and milestone-driven portfolio by targeting biotech firms with high-risk, high-reward therapeutic assets.

Under the terms of the deal announced June 27, XOMA Royalty will pay $0.34 per share in cash to Turnstone shareholders, along with a non-transferable CVR tied to future clinical or commercial milestones. The transaction was unanimously approved by Turnstone’s board following a comprehensive strategic review, indicating strong alignment between both companies on the benefits of the proposed merger.

The transaction will be executed through a tender offer, which XOMA is expected to launch by July 11, 2025. To move forward, the offer requires acceptance by holders representing at least a majority of Turnstone’s outstanding shares, along with other standard closing conditions including a minimum cash balance at the time of closing.

Significantly, shareholders representing roughly 25.2% of Turnstone’s stock have already agreed to support the deal and tender their shares, increasing the likelihood of a successful outcome. If the tender offer is completed as planned, remaining shares not tendered—excluding any subject to appraisal rights—will be converted into the same cash and CVR terms. The full acquisition is anticipated to close by August 2025.

The CVR element of the deal provides Turnstone shareholders with potential upside depending on the progress of its pipeline, which historically has focused on Selected Tumor-Infiltrating Lymphocyte (Selected TIL) therapy for the treatment of solid tumors. While the company has faced challenges in recent quarters, its research has positioned it within a promising niche of the immuno-oncology space.

Turnstone has partnered with Leerink Partners as financial advisor and Cooley LLP for legal counsel during the transaction process. On the acquiring side, XOMA is represented by legal firm Gibson, Dunn & Crutcher LLP.

This acquisition adds another layer to XOMA’s unique business model, which focuses on purchasing future economic rights—royalties and milestone payments—from pre-commercial and commercial biotech programs. These rights are typically tied to therapies developed and licensed out by smaller biotech companies to larger pharmaceutical firms. In return, the selling firms receive non-dilutive capital they can reinvest into pipeline development or general operations.

By bringing Turnstone into its fold, XOMA potentially gains exposure to novel cancer therapies while giving Turnstone a viable financial exit at a time when biotech funding remains tight. The CVR component allows existing shareholders to benefit from any future success tied to Turnstone’s core scientific work, creating a hybrid payout structure aligned with both short-term liquidity and long-term optionality.

The transaction reflects a growing trend in biotech M&A, where royalty aggregators like XOMA leverage strategic acquisitions to build long-term value while offering capital relief to development-stage firms.

As of now, both companies remain focused on a smooth closing process, with investors watching closely to see how Turnstone’s science and XOMA’s model will align in the quarters ahead.

CoreWeave Pursues $4B Deal to Power AI Ambitions with Core Scientific

CoreWeave, the rapidly rising AI cloud infrastructure provider, is once again making headlines — this time for reigniting acquisition talks with bitcoin mining giant Core Scientific. According to a report by The Wall Street Journal, the companies are in advanced discussions that could lead to a deal in the coming weeks, pending negotiations.

The move marks a notable turn in a high-stakes courtship that began last year, when CoreWeave made an unsolicited offer to acquire Core Scientific for $1.02 billion. That bid, valued at $5.75 per share, was promptly rejected by Core Scientific for undervaluing the company. Fast-forward a year, and Core Scientific’s market value has climbed to nearly $4 billion, with shares rising roughly 8% following the renewed acquisition chatter.

CoreWeave’s interest in the company is strategic. As AI workloads continue to demand massive computational power and access to stable energy supplies, former crypto mining operations like Core Scientific have become increasingly attractive targets. With expansive infrastructure already in place, these facilities offer AI players a fast track to scaling data centers without starting from scratch.

CoreWeave and Core Scientific already have history. Following the failed acquisition attempt in 2024, the companies entered a multi-decade partnership involving 12-year infrastructure contracts. Among them was a landmark deal in which Core Scientific committed to providing CoreWeave with 200 megawatts of power capacity to support its high-performance computing operations. That agreement alone signaled a convergence between the worlds of cryptocurrency and artificial intelligence — both of which depend on energy-intensive server farms.

The potential acquisition now appears to be a natural next step in that partnership. By bringing Core Scientific under its umbrella, CoreWeave would not only secure long-term access to critical power infrastructure but also strengthen its foothold in the competitive AI cloud race — a space dominated by the likes of Amazon, Google, and Microsoft.

While the exact financial terms of the revived offer have not been disclosed, market analysts suggest any deal would likely exceed the previous $1 billion bid, given Core Scientific’s increased valuation and rising relevance in the post-crypto AI landscape.

Still, a finalized agreement is not guaranteed. Regulatory scrutiny, shifting market conditions, or resistance from shareholders could delay or derail the talks. Neither Core Scientific nor CoreWeave has publicly commented on the latest developments.

The acquisition would mark another significant move in a broader trend: tech and AI companies consolidating energy assets and computing infrastructure once built for cryptocurrency mining. As AI continues to evolve and expand, the race to control the digital and physical backbones of computation is heating up — and CoreWeave is positioning itself at the center.

Mortgage Rates Fall Below 6.8%, Offering Little Spark for Home Sales

Key Points:
– Mortgage rates fell to 6.77%, the lowest since May, as Treasury yields dipped.
– High rates and home prices continue to constrain homebuyer activity.
– Forecasters expect only modest rate relief through the end of the year.

Mortgage rates have inched lower for a fourth straight week, offering a glimmer of relief for homebuyers, but not enough to spark a major rebound in the housing market. The average 30-year fixed mortgage rate dropped to 6.77% this week, its lowest level since May, down slightly from 6.81% last week, according to data from Freddie Mac. The average rate for a 15-year mortgage also dipped to 5.89% from 5.96%.

This modest decline comes as geopolitical tensions ease and Treasury yields soften. A recent ceasefire between Iran and Israel helped calm global markets, while dovish comments from Federal Reserve officials increased expectations that rate cuts could come as early as July. These factors contributed to a dip in the 10-year Treasury yield, which mortgage rates tend to closely follow.

Though the Federal Reserve has not moved to lower interest rates yet, speculation around future cuts is already influencing mortgage rate behavior. Fed Chair Jerome Powell reiterated during recent congressional testimony that while rate cuts are not imminent, the central bank remains open to adjusting policy if inflation continues to cool or if economic conditions shift.

Despite the recent rate movement, mortgage rates are still hovering near the upper end of a narrow range. Since mid-April, rates have fluctuated within a tight 15-basis-point band, limiting their ability to meaningfully impact housing affordability.

High borrowing costs, coupled with persistently high home prices, have continued to dampen housing activity. While pending home sales rose by 1.8% in May from the previous month, and 1.1% year-over-year, the overall housing market remains subdued. New home sales, in contrast, fell sharply last month, plunging 14% — the steepest monthly drop in three years, highlighting buyer hesitation in the current rate environment.

Mortgage applications for new purchases were essentially flat last week, according to the Mortgage Bankers Association, while refinancing activity saw a modest 3% increase. The latter suggests that some homeowners are finding incentive in even small rate drops to restructure their existing loans, though the overall refinancing market remains a fraction of what it was during the ultra-low rate environment of the pandemic.

Looking ahead, economists expect only gradual improvement. The Mortgage Bankers Association projects rates to close out the year around 6.7%, while Fannie Mae anticipates a slightly more optimistic 6.5%. Either way, most forecasts suggest a slow decline rather than a swift return to significantly lower levels.

For prospective buyers, this means affordability may improve modestly, but major relief remains unlikely in the short term. With inflation, Federal Reserve policy, and global uncertainty still in play, the mortgage market is expected to remain cautious.

Steelcase (SCS) – First Look At A Solid First Quarter


Thursday, June 26, 2025

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

1Q26. Steelcase reported solid results for the first quarter of fiscal 2026. Revenue grew 7% y-o-y to $779 million, towards the upper end of guidance. We had forecast $760 million and the consensus was $762 million. Gross margin of 33.9% was up 170 bp y-o-y and above management’s 33% guide. Steelcase reported net income of $13.6 million, or EPS of $0.11, and adjusted EPS of $0.20, compared to $10.9 million, $0.09, and $0.16, respectively, last year. We were at adjusted EPS of $0.14, while consensus was $0.13.

Quarterly Drivers. The Americas business was up 9%, both on a reported and organic basis, driven by a higher beginning backlog compared to the prior year and included strong growth from large corporate, government, and healthcare customers. International was up 1% on a reported basis but down 1% on an organic basis, driven by declines in Germany and France, mostly offset by growth in India, the UK, and China.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Nvidia Eyes Robotics as Its Next Trillion-Dollar Frontier

Key Points:
– Nvidia identifies robotics as its next major growth driver, second only to artificial intelligence, with self-driving cars and humanoid robots as early focus areas.
– Robotics and automotive revenue is currently small—just 1% of total sales—but growing rapidly, with 72% annual growth reported last quarter.
– Nvidia is evolving into a full AI infrastructure provider, offering chips, software, and cloud services to power future autonomous systems and robotics at scale.

Nvidia, the global leader in AI computing and graphics processing, is turning its attention to robotics as its next major growth engine—second only to artificial intelligence itself. During its annual shareholders meeting, CEO Jensen Huang outlined how robotics could transform from a niche revenue stream into a multitrillion-dollar opportunity for the company.

While Nvidia is best known today for the chips that power generative AI tools like ChatGPT, its ambitions are quickly expanding beyond data centers. Robotics, according to Huang, is poised to become one of the largest markets for Nvidia’s technology—integrating AI with physical systems across industries from transportation to manufacturing.

Currently, Nvidia’s automotive and robotics business makes up a small fraction of the company’s total revenue. In the most recent quarterly report, that segment generated $567 million, accounting for about 1% of total revenue. However, it showed strong momentum, up 72% year-over-year. Huang emphasized that this is only the beginning of what he sees as a long-term play.

One of the most immediate commercial applications of robotics, according to Nvidia, is autonomous vehicles. The company’s Drive platform—already adopted by major carmakers like Mercedes-Benz—includes powerful onboard chips and AI models capable of handling the complex task of self-driving navigation. But Nvidia’s robotics vision extends far beyond the road.

At the meeting, Huang also spotlighted the company’s newly released Cosmos AI models for humanoid robots. These models represent a leap toward enabling general-purpose robots that can interact with and adapt to dynamic environments. From warehouse automation to robotic factories and healthcare assistants, Nvidia sees its chips playing a central role in bringing these systems to life.

To support these ambitions, Nvidia continues to evolve its identity from a chip manufacturer to a full-fledged AI infrastructure provider. In addition to its industry-dominating GPUs, the company now offers networking hardware, enterprise software, and its own cloud services—all designed to create a seamless pipeline from model training to deployment in the real world.

Huang’s comments reflect Nvidia’s long-term strategy to build an end-to-end ecosystem for intelligent computing. With demand for AI capabilities showing no sign of slowing and emerging use cases like robotics gaining traction, the company appears well-positioned to lead in both digital and physical AI applications.

The financial markets appear to agree. Nvidia’s stock surged to a record high following the shareholder meeting, pushing its market capitalization to $3.75 trillion—surpassing Microsoft to become the most valuable public company in the world.

Although robotics currently represents a small sliver of Nvidia’s earnings, the strategic importance of this segment is growing. As more industries invest in automation and intelligent systems, Nvidia is betting that the same technology powering chatbots and data centers will eventually control fleets of robots, smart factories, and autonomous machines across the globe.

With the groundwork now in place, Nvidia is not just building chips—it’s building the future of intelligent automation.

Rubrik to Acquire AI Startup Predibase in Strategic Expansion Push

Key Points:
– Rubrik is acquiring AI startup Predibase for over $100 million to expand into enterprise AI infrastructure.
– Predibase’s platform allows businesses to customize and deploy AI models using data from third-party sources.
– The acquisition aligns with Rubrik’s strategy to evolve into a multi-product enterprise platform focused on security and AI innovation.

Rubrik, the data security and management company, is set to acquire artificial intelligence startup Predibase in a move that deepens its presence in the fast-growing AI infrastructure market. The acquisition, valued at over $100 million according to a source familiar with the terms, marks a significant step in Rubrik’s efforts to broaden its capabilities beyond data backup and cyber resilience.

Predibase, founded in 2021, specializes in tools that help organizations efficiently deploy custom AI models using their own data. The San Francisco-based startup has attracted attention for its developer-focused platform that integrates with a wide range of third-party data systems. By enabling customization and deployment of large language models (LLMs), Predibase aims to help businesses move beyond generic AI tools and build solutions tailored to their internal data needs.

Rubrik, which went public in 2024 and has seen robust revenue growth since its IPO, views the deal as an opportunity to evolve into a multi-product enterprise software provider. The company has already established itself as a key player in data protection and ransomware recovery, boasting more than $1 billion in annualized recurring revenue. The integration of Predibase’s AI model deployment tools adds a new layer to Rubrik’s offerings—one that taps into the increasing demand for AI-powered automation across enterprises.

With this acquisition, Rubrik aims to give customers the ability to build secure, cost-effective AI agents that can reason over large datasets housed within both Rubrik’s ecosystem and external cloud platforms. These include major cloud data players such as Amazon Web Services, Google Cloud, Snowflake, and Databricks, with whom Predibase already integrates.

The Predibase platform will continue to operate independently after the acquisition closes, preserving its existing customer relationships and developer-centric approach. Predibase’s technology will also be enhanced by Rubrik’s Annapurna platform, which enables secure aggregation of data from multiple sources. Together, the two platforms are expected to provide businesses with an end-to-end stack for building and deploying AI models grounded in private enterprise data.

Predibase’s team, including co-founders who previously worked on AI infrastructure at Uber, brings technical depth and credibility to Rubrik’s expanding AI strategy. Their work at Uber on machine learning platforms laid the groundwork for scalable AI services, and they bring similar ambitions to their new parent company.

For Rubrik, the acquisition underscores a broader ambition to become a long-term platform player in the enterprise technology space. As more businesses look to harness generative AI for insights and automation, the demand for tools that enable secure, high-performance model training and deployment is growing rapidly. With Predibase now in its fold, Rubrik is positioning itself to be at the center of this next wave of enterprise AI adoption.